Detalhe da pesquisa
1.
Pregnancy and Birth Outcomes in Patients With Multidrug-Resistant Tuberculosis Treated With Regimens That Include New and Repurposed Drugs.
Clin Infect Dis
; 78(1): 144-148, 2024 01 25.
Artigo
Inglês
| MEDLINE | ID: mdl-37606512
2.
Effectiveness of Bedaquiline Use beyond Six Months in Patients with Multidrug-Resistant Tuberculosis.
Am J Respir Crit Care Med
; 207(11): 1525-1532, 2023 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36802336
3.
Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort.
Clin Infect Dis
; 75(6): 1006-1013, 2022 09 29.
Artigo
Inglês
| MEDLINE | ID: mdl-35028659
4.
Safety and Effectiveness Outcomes From a 14-Country Cohort of Patients With Multi-Drug Resistant Tuberculosis Treated Concomitantly With Bedaquiline, Delamanid, and Other Second-Line Drugs.
Clin Infect Dis
; 75(8): 1307-1314, 2022 10 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35243494
5.
All-oral longer regimens are effective for the management of multidrug-resistant tuberculosis in high-burden settings.
Eur Respir J
; 59(1)2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34140298
6.
Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid. A Prospective Multicountry Study.
Am J Respir Crit Care Med
; 203(1): 111-119, 2021 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32706644
7.
Culture Conversion at 6 Months in Patients Receiving Delamanid-containing Regimens for the Treatment of Multidrug-resistant Tuberculosis.
Clin Infect Dis
; 71(2): 415-418, 2020 07 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31676905
8.
The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens.
BMC Infect Dis
; 19(1): 733, 2019 Aug 20.
Artigo
Inglês
| MEDLINE | ID: mdl-31429722
9.
Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial.
Am J Respir Crit Care Med
; 198(5): 657-666, 2018 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29954183
10.
Corrigendum to 'High prevalence of hepatitis C infection among multidrug-resistant tuberculosis patients' [J Hepatol 72 (2020) 1028-1029].
J Hepatol
; 77(2): 583, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-35581037
11.
Multidrug-Resistant Tuberculosis Treatment in North Korea: Is Scale-Up Possible?
PLoS Med
; 13(8): e1002062, 2016 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27483430
12.
High prevalence of hepatitis C infection among multidrug-resistant tuberculosis patients.
J Hepatol
; 72(5): 1028-1029, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32147086
13.
Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis.
Clin Infect Dis
; 59(10): 1364-74, 2014 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-25097082
14.
Sputum culture reversion in longer treatments with bedaquiline, delamanid, and repurposed drugs for drug-resistant tuberculosis.
Nat Commun
; 15(1): 3927, 2024 May 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38724531
15.
Effectiveness of a bedaquiline, linezolid, clofazimine "core" for multidrug-resistant tuberculosis.
medRxiv
; 2024 Jan 19.
Artigo
Inglês
| MEDLINE | ID: mdl-38293100
16.
Comparative effectiveness of adding delamanid to a multidrug-resistant tuberculosis regimen comprised of three drugs likely to be effective.
PLOS Glob Public Health
; 3(4): e0000818, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37115740
17.
Comprehensive treatment of extensively drug-resistant tuberculosis.
N Engl J Med
; 359(6): 563-74, 2008 Aug 07.
Artigo
Inglês
| MEDLINE | ID: mdl-18687637
18.
INCIDENCE OF HIGH GRADE QTCF PROLONGATION AND ITS MANAGEMENT AMONG PATIENTS UNDERGOING TREATMENT FOR DRUG RESISTANT TUBERCULOSIS (DR-TB): CASE SERIES.
Afr J Infect Dis
; 15(2 Suppl): 38-41, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34595385
19.
Culture conversion at six months in patients receiving bedaquiline- and delamanid-containing regimens for the treatment of multidrug-resistant tuberculosis.
Int J Infect Dis
; 113 Suppl 1: S91-S95, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-33823277
20.
Agreement between physicians and non-physician clinicians in starting antiretroviral therapy in rural Uganda.
Hum Resour Health
; 7: 75, 2009 Aug 20.
Artigo
Inglês
| MEDLINE | ID: mdl-19695083